The invention relates to an oligodextran selected from among dextrans having an average degree of polymerisation of less than 10, modified by at least one substituent having general formula (I): -R1-[[AA]-[R2]n]m.The invention also relates to a pharmaceutical composition characterised in that it comprises an oligosaccharide according to the invention and an active principle is selected from the group containing proteins, glycoproteins, peptides and non-peptide therapeutic molecules.
展开▼
机译：本发明涉及一种平均聚合度小于10的葡聚糖低聚葡聚糖，其被至少一个具有通式（I）的取代基改性：-R 1 -[[AA]- [R 2 ] n ] m 。本发明还涉及药物组合物，其特征在于其包含根据本发明的寡糖和活性成分选自蛋白质，糖蛋白，肽和非肽治疗性分子。
展开▼
